Tag: Medicines Australia
-
JAKs duke it out for Humira territory
- 26 May 2021
Pfizer’s successful complaint against AbbVie fuels industry concerns about the practical application of the new principles-based Code.
Read more -
MA agreement ‘delayed by Covid’
- 10 May 2021
Medicines Australia CEO Liz de Somer reveals new timeframe for when she expects the innovative industry’s next five-year agreement to be inked.
Read more -
Compassionate access register coming
- 29 Mar 2021
Medicines Australia working with cancer clinicians on ‘prototype’ patient access program database.
Read more